Redistribution of garbage codes to underlying causes of death: a systematic analysis on Italy and a comparison with most populous Western European countries based on the Global Burden of Disease Study 2019.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 06 2022
Historique:
pubmed: 22 1 2022
medline: 7 6 2022
entrez: 21 1 2022
Statut: ppublish

Résumé

The proportion of reported causes of death (CoDs) that are not underlying causes can be relevant even in high-income countries and seriously affect health planning. The Global Burden of Disease (GBD) study identifies these 'garbage codes' (GCs) and redistributes them to underlying causes using evidence-based algorithms. Planners relying on vital registration data will find discrepancies with GBD estimates. We analyse these discrepancies, through the analysis of GCs and their redistribution. We explored the case of Italy, at national and regional level, and compared it to nine other Western European countries with similar population sizes. We analysed differences between official data and GBD 2019 estimates, for the period 1990-2017 for which we had vital registration data for most select countries. In Italy, in 2017, 33 000 deaths were attributed to unspecified type of stroke and 15 000 to unspecified type of diabetes, these making a fourth of the overall garbage. Significant heterogeneity exists on the overall proportion of GCs, type (unspecified or impossible underlying causes), and size of specific GCs among regions in Italy, and among the select countries. We found no pattern between level of garbage and relevance of specific GCs. Even locations performing below average show interesting lower levels for certain GCs if compared to better performing countries. This systematic analysis suggests the heterogeneity in GC levels and causes, paired with a more detailed analysis of local practices, strengths and weaknesses, could be a positive element in a strategy for the reduction of GCs in Italy.

Sections du résumé

BACKGROUND
The proportion of reported causes of death (CoDs) that are not underlying causes can be relevant even in high-income countries and seriously affect health planning. The Global Burden of Disease (GBD) study identifies these 'garbage codes' (GCs) and redistributes them to underlying causes using evidence-based algorithms. Planners relying on vital registration data will find discrepancies with GBD estimates. We analyse these discrepancies, through the analysis of GCs and their redistribution.
METHODS
We explored the case of Italy, at national and regional level, and compared it to nine other Western European countries with similar population sizes. We analysed differences between official data and GBD 2019 estimates, for the period 1990-2017 for which we had vital registration data for most select countries.
RESULTS
In Italy, in 2017, 33 000 deaths were attributed to unspecified type of stroke and 15 000 to unspecified type of diabetes, these making a fourth of the overall garbage. Significant heterogeneity exists on the overall proportion of GCs, type (unspecified or impossible underlying causes), and size of specific GCs among regions in Italy, and among the select countries. We found no pattern between level of garbage and relevance of specific GCs. Even locations performing below average show interesting lower levels for certain GCs if compared to better performing countries.
CONCLUSIONS
This systematic analysis suggests the heterogeneity in GC levels and causes, paired with a more detailed analysis of local practices, strengths and weaknesses, could be a positive element in a strategy for the reduction of GCs in Italy.

Identifiants

pubmed: 35061890
pii: 6513621
doi: 10.1093/eurpub/ckab194
pmc: PMC9159332
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-462

Investigateurs

Lorenzo Monasta (L)
Gianfranco Alicandro (G)
Maja Pasovic (M)
Matthew Cunningham (M)
Benedetta Armocida (B)
Luciana Albano (L)
Ettore Beghi (E)
Massimiliano Beghi (M)
Cristina Bosetti (C)
Nicola Luigi Bragazzi (NL)
Giulia Carreras (G)
Giulio Castelpietra (G)
Alberico L Catapano (AL)
Maria Sofia Cattaruzza (MS)
Giulia Collatuzzo (G)
Sara Conti (S)
Giovanni Damiani (G)
Pietro Ferrara (P)
Carla Fornari (C)
Silvano Gallus (S)
Simona Giampaoli (S)
Davide Golinelli (D)
Gaetano Isola (G)
Paolo Lauriola (P)
Carlo La Vecchia (C)
Matilde Leonardi (M)
Francesca Giulia Magnani (FG)
Giada Minelli (G)
Marcello Moccia (M)
Paolo Pedersini (P)
Norberto Perico (N)
Alberto Raggi (A)
Giuseppe Remuzzi (G)
Francesco Sanmarchi (F)
Davide Sattin (D)
Brigid Unim (B)
Jorge Hugo Villafañe (JH)
Francesco S Violante (FS)
Christopher J L Murray (CJL)
Luca Ronfani (L)
Mohsen Naghavi (M)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association.

Références

J Korean Med Sci. 2016 Nov;31 Suppl 2:S121-S128
pubmed: 27775249
BMC Med Inform Decis Mak. 2021 Jun 2;21(1):175
pubmed: 34078366
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
BMC Med. 2020 Mar 9;18(1):55
pubmed: 32146899
PLoS Med. 2016 Jun 28;13(6):e1002056
pubmed: 27351744
Epidemiol Prev. 2021 May-Jun;45(3):130-131
pubmed: 34212687
Popul Health Metr. 2010 May 10;8:9
pubmed: 20459720
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Bull World Health Organ. 2014 Nov 1;92(11):807-16
pubmed: 25378742
Popul Health Metr. 2014 Feb 17;12(1):3
pubmed: 24533639
Arch Public Health. 2021 Mar 15;79(1):33
pubmed: 33722272
ACM BCB. 2018 Aug;2018:178-183
pubmed: 32558825
J Clin Pathol. 2002 Apr;55(4):275-9
pubmed: 11919211
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Epidemiol Prev. 2019 Mar-Jun;43(2-3):161-170
pubmed: 31293135
Am J Public Health. 2020 Feb;110(2):222-229
pubmed: 31855478

Auteurs

Lorenzo Monasta (L)

Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.

Gianfranco Alicandro (G)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Maja Pasovic (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Matthew Cunningham (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Benedetta Armocida (B)

Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.

Christopher J L Murray (C)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.

Luca Ronfani (L)

Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.

Mohsen Naghavi (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH